Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 1,063.20 | 1,525.30 | 1,024.14 | 994.24 | 846.43 |
| Operating profit | 151.63 | 389.64 | 125.53 | 86.16 | 16.59 |
| Interest | 24.88 | 27.66 | 17.42 | 28.22 | 33.80 |
| Gross profit | 163.51 | 415.17 | 141.22 | 147.02 | 9.47 |
| EPS (Rs) | 0.64 | 2.06 | 0.56 | 0.58 | -0.28 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 36.76 | 53.19 | 33.11 | 89.08 | 26.68 |
| Stock adjustment | -132.35 | 135.74 | -120.72 | -11.59 | -65.05 |
| Raw material | 405.76 | 417.52 | 444.94 | 356.76 | 326.33 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 186.96 | 152.88 | 150.56 | 151.44 | 159.05 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 451.20 | 429.52 | 423.83 | 411.47 | 409.51 |
| Provisions made | - | - | - | - | - |
| Depreciation | 51.85 | 52.50 | 51.56 | 50.83 | 50.37 |
| Taxation | 26.39 | 89.59 | 15.32 | 19.03 | -7.54 |
| Net profit / loss | 85.27 | 273.08 | 74.34 | 77.16 | -33.36 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 1,322.95 | 1,322.95 | 1,322.95 | 1,322.95 | 1,193.32 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 14.26 | 25.55 | 12.26 | 8.67 | 1.96 |
| GPM (%) | 14.87 | 26.30 | 13.36 | 13.57 | 1.08 |
| NPM (%) | 7.75 | 17.30 | 7.03 | 7.12 | -3.82 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis